Agency Information Collection Activities: Proposed Collection: Public Comment Request, 79593-79594 [2015-32004]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices
Place: CDC, 4770 Buford Highway,
Chamblee Building 106 1A/1B, Atlanta,
Georgia 30341.
This meeting is also accessible by
teleconference and web access.
Teleconference and web access login
information are as follows:
Toll-Free Telephone: 1–888–972–9241,
Participant passcode: 8025509.
Net Conference and Web Url:
For January 28, 2016: https://www.my
meetings.com/nc/join/.
Conference number: PW6371280,
Audience passcode: 8025509.
Participants can join the event directly at:
https://www.mymeetings.com/nc/join.php?i=
PW6371280&p=8025509&t=c.
For January 29, 2016: https://www.my
meetings.com/nc/join/.
Conference number: PW6371295,
Audience passcode: 8025509.
Participants can join the event directly at:
https://www.mymeetings.com/nc/join.php?i=
PW6371295&p=8025509&t=c.
Status: Open to the public, limited only by
the space and audio phone lines available.
Purpose: The committee provides advice
and guidance to the Secretary, HHS; the
Assistant Secretary for Health; and the
Director, CDC, regarding the formative
research, development, implementation and
evaluation of evidence-based activities
designed to prevent breast cancer
(particularly among those at heightened risk)
and promote the early detection and support
of young women who develop the disease.
The advice provided by the Committee will
assist in ensuring scientific quality,
timeliness, utility, and dissemination of
credible appropriate messages and resource
materials.
Matters for Discussion: The agenda will
include discussions on the current and
emerging topics related to breast cancer in
young women. These will include public
health communication, breast cancer in
young women digital and social media
campaigns, and CDC updates. Topics will
address efforts to increase awareness around
breast cancer risk, breast health, symptoms,
diagnosis, and treatment of breast cancer in
young women.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: In order to
expedite the security clearance process
required for entry into a Federal building, all
ACBCYW attendees must register for the
meeting online at least 7 business days in
advance at https://www.cdc.gov/cancer/
breast/what_cdc_is_doing/meetings.htm.
Please complete all the required fields before
submitting your registration and submit no
later than January 19, 2016. Each meeting
day, attendees must provide CDC staff and
security with driver’s license/state issued ID,
or passport.
Contact Person For More Information:
Temeika L. Fairley, Ph.D., Designated Federal
Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 5770
Buford Hwy. NE., Mailstop K52, Atlanta,
Georgia 30341, Telephone (770) 488–4518,
Fax (770) 488–4760. Email: acbcyw@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
VerDate Sep<11>2014
19:09 Dec 21, 2015
Jkt 238001
79593
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and Agency for Toxic Substances
and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request
[FR Doc. 2015–32015 Filed 12–21–15; 8:45 am]
BILLING CODE 4163–18–P
Health Resources and Services
Administration
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects (Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995), the
Health Resources and Services
Administration (HRSA) announces
plans to submit an Information
Collection Request (ICR), described
below, to the Office of Management and
Budget (OMB). Prior to submitting the
ICR to OMB, HRSA seeks comments
from the public regarding the burden
estimate, below, or any other aspect of
the ICR.
DATES: Comments on this Information
Collection Request must be received no
later than February 19, 2016.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 10–29, Parklawn
Building, 5600 Fishers Lane, Rockville,
MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call the HRSA Information Collection
Clearance Officer at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
This notice was published
in the Federal Register on December 14,
2015, Volume 80, Number 239, Page
77352. The Dial-in number should read
as follows to include additional lines for
public participation and to provide for
people with disabilities:
Teleconference Dial-In Number: 1–
888–469–1243, Participant Code:
4709506
TTY Accessible link: https://www.
captionedtext.com/client/event.aspx?
CustomerID=1891&EventID=2812715
CDC encourages participation by
persons with disabilities. Captions and
participation by persons with
communications challenges will be
available online via Relay Conference
Captioning. To view the online captions
at the start time of the event, please
login for captioning at: https://www.
captionedtext.com/client/event.aspx?
CustomerID=1891&EventID=2812715.
Contact Person For More Information:
Arlene Greenspan, DrPH, M.P.H., P.T.
Associate Director for Science, NCIPC,
CDC, 4770 Buford Highway NE.,
Mailstop F–63, Atlanta, GA 30341,
Telephone (770) 488–4696.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
AMENDMENT:
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32016 Filed 12–21–15; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Information Collection Request Title:
HRSA National Environmental Policy
Act (NEPA) Environmental Information
and Documentation (EID) OMB No.
0915–0324—Extension
Abstract: HRSA is requesting
extension of the approval for the
Environmental Information and
Documentation (EID) checklist which
consists of information that the agency
is required to obtain to comply with the
National Environmental Policy Act of
1969 (NEPA). NEPA establishes the
federal government’s national policy for
protection of the environment. HRSA
has developed the EID for applicants of
funding that would potentially impact
the environment and to ensure that their
E:\FR\FM\22DEN1.SGM
22DEN1
79594
Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices
decision-making processes are
consistent with NEPA.
Need and Proposed Use of the
Information: Applicants must provide
information and assurance of
compliance with NEPA on the EID
checklist. This information is reviewed
in the Pre-Award stage.
Likely Respondents: HRSA applicants
applying for federal construction grants
and cooperative agreements.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
Number of
respondents
Form name
Number of
responses per
respondent
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
Total Estimated Annualized burden
hours:
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
NEPA EID Checklist ............................................................
1,350
1
1,350
1.0
1,350
Total ..............................................................................
1,350
1
1,350
1.0
1,350
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015–32004 Filed 12–21–15; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 209 and 37 CFR part 404 to
achieve expeditious commercialization
of results of federally-funded research
and development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by emailing the
indicated licensing contact at the
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:21 Dec 21, 2015
Jkt 238001
National Heart, Lung, and Blood, Office
of Technology Transfer and
Development Office of Technology
Transfer, 31 Center Drive Room 4A29,
MSC2479, Bethesda, MD 20892–2479;
telephone: 301–402–5579. A signed
Confidential Disclosure Agreement may
be required to receive copies of the
patent applications.
SUPPLEMENTARY INFORMATION:
Technology description follows.
Metallic Nanoparticles for
Photothermal Therapy
Description of Technology: The
invention relates to the preparation and
application of 20–150nm metallic
nanoparticulate vesicles for
photothermal anti-cancer therapy. The
vesicles comprise metallic nanoparticles
covalently bound to a hydrophilic and
hydrophobic polymer. The preparation
method generally entails dispersing a
polymer-bound metallic nanoparticle in
an organic solvent, adding an aqueous
solution with a dispersing aid,
sonicating the mixture, and finally
removing the organic solvent until the
vesicle forms. The final vesicle is stable
wherein the metallic nanoparticle is
covalently bound to the hydrophobic
and hydrophilic polymer. By way of a
non-limiting example, an exemplary
vesicles can be one made from gold
nanorods coated with polyethylene
glycol and polylactic-co-glycolic acid
(AuNR@PEG/PLGA) in an oil-in-water
emulsion.
Potential Commercial Applications:
• Cancer therapy
• Tumor therapy
Competitive Advantages:
• Prolonged circulation
• High tumor accumulation
• Rapid excretion
• Enhanced photoacoustic signal
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
• Enhanced photothermal effect/cancer
therapy efficacy.
Development Stage:
• In vitro data
Inventors: Xiaoyuan (Shawn) Chen
and Jibin Song (both of NIBIB).
Intellectual Property: HHS Reference
No. E–158–2015/0–US–01.
• U.S. Provisional Patent Application
62/226,289 filed December 11, 2015.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@mail.nih.gov.
Collaborative Research Opportunity:
The National Institute of Biomedical
Imaging and Bioengineering seeks
statements of capability or interest from
parties interested in collaborative
research to further develop and evaluate
metallic nanoparticle vesicles for cancer
phototherapy. For collaboration
opportunities, please contact Cecilia
Pazman, Ph.D. at
pazmance@nhlbi.nih.gov.
Dated: December 15, 2015.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
[FR Doc. 2015–32096 Filed 12–21–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of an Exclusive
Start-Up Option License: Potent and
Selective Analogues of Monamine
Transporters; Methods of Making; and
Uses Thereof
National Institutes of Health,
Public Health Service, HHS.
AGENCY:
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 80, Number 245 (Tuesday, December 22, 2015)]
[Notices]
[Pages 79593-79594]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32004]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Public Comment Request
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement for opportunity for public
comment on proposed data collection projects (Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995), the Health Resources and Services
Administration (HRSA) announces plans to submit an Information
Collection Request (ICR), described below, to the Office of Management
and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks
comments from the public regarding the burden estimate, below, or any
other aspect of the ICR.
DATES: Comments on this Information Collection Request must be received
no later than February 19, 2016.
ADDRESSES: Submit your comments to paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance Officer, Room 10-29, Parklawn
Building, 5600 Fishers Lane, Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
draft instruments, email paperwork@hrsa.gov or call the HRSA
Information Collection Clearance Officer at (301) 443-1984.
SUPPLEMENTARY INFORMATION: When submitting comments or requesting
information, please include the information request collection title
for reference.
Information Collection Request Title: HRSA National Environmental
Policy Act (NEPA) Environmental Information and Documentation (EID) OMB
No. 0915-0324--Extension
Abstract: HRSA is requesting extension of the approval for the
Environmental Information and Documentation (EID) checklist which
consists of information that the agency is required to obtain to comply
with the National Environmental Policy Act of 1969 (NEPA). NEPA
establishes the federal government's national policy for protection of
the environment. HRSA has developed the EID for applicants of funding
that would potentially impact the environment and to ensure that their
[[Page 79594]]
decision-making processes are consistent with NEPA.
Need and Proposed Use of the Information: Applicants must provide
information and assurance of compliance with NEPA on the EID checklist.
This information is reviewed in the Pre-Award stage.
Likely Respondents: HRSA applicants applying for federal
construction grants and cooperative agreements.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this Information Collection Request are summarized in the table below.
Total Estimated Annualized burden hours:
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of Total burden per Total burden
Form name respondents responses per responses response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
NEPA EID Checklist.............. 1,350 1 1,350 1.0 1,350
-------------------------------------------------------------------------------
Total....................... 1,350 1 1,350 1.0 1,350
----------------------------------------------------------------------------------------------------------------
HRSA specifically requests comments on (1) the necessity and
utility of the proposed information collection for the proper
performance of the agency's functions, (2) the accuracy of the
estimated burden, (3) ways to enhance the quality, utility, and clarity
of the information to be collected, and (4) the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015-32004 Filed 12-21-15; 8:45 am]
BILLING CODE 4165-15-P
